ATE401337T1 - Antiangiogene polypeptide - Google Patents

Antiangiogene polypeptide

Info

Publication number
ATE401337T1
ATE401337T1 AT01987119T AT01987119T ATE401337T1 AT E401337 T1 ATE401337 T1 AT E401337T1 AT 01987119 T AT01987119 T AT 01987119T AT 01987119 T AT01987119 T AT 01987119T AT E401337 T1 ATE401337 T1 AT E401337T1
Authority
AT
Austria
Prior art keywords
polypeptides
antiangiogenic polypeptides
antiangiogenic
disclosed
methods
Prior art date
Application number
AT01987119T
Other languages
English (en)
Inventor
David M Waisman
Geetha Kassam
Mijung Kwon
Original Assignee
David M Waisman
Geetha Kassam
Mijung Kwon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David M Waisman, Geetha Kassam, Mijung Kwon filed Critical David M Waisman
Application granted granted Critical
Publication of ATE401337T1 publication Critical patent/ATE401337T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT01987119T 2000-11-28 2001-11-28 Antiangiogene polypeptide ATE401337T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25372500P 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
ATE401337T1 true ATE401337T1 (de) 2008-08-15

Family

ID=22961462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01987119T ATE401337T1 (de) 2000-11-28 2001-11-28 Antiangiogene polypeptide

Country Status (8)

Country Link
US (2) US7420036B2 (de)
EP (1) EP1337548B1 (de)
CN (1) CN100491394C (de)
AT (1) ATE401337T1 (de)
AU (1) AU2002239366A1 (de)
CA (1) CA2426543C (de)
DE (1) DE60134885D1 (de)
WO (1) WO2002044328A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100491394C (zh) 2000-11-28 2009-05-27 大卫·M·崴斯曼 抗血管增生的多肽
WO2003045323A2 (en) 2001-11-28 2003-06-05 Mediomics, Llc Anti-angiogenesis methods, compositions and uses therefor
US7893033B2 (en) 2002-05-06 2011-02-22 Board Of Regents, The University Of Texas System Targeting proteins to deliver therapeutic or diagnostic reagents
WO2004054517A2 (en) 2002-12-13 2004-07-01 Mediomics, Llc Compositions and methods for inhibiting tumor growth and metastasis
WO2006075165A1 (en) * 2005-01-13 2006-07-20 Btg International Limited Combination of oncolytic viruses with angiogenesis inhibitors
CN101219219B (zh) * 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
EP0467987A4 (en) 1989-05-01 1992-07-08 The University Of Notre Dame Du Lac Methods and materials for expression of human plasminogen in a eukaryotic cell system
US5945403A (en) 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US5837682A (en) 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
ATE299888T1 (de) 1996-05-03 2005-08-15 Abbott Lab Antiangiogenische peptiden, dafür kodierende polynukleotide und verfahren zur hemmung der angiogenesis
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
AU7951798A (en) 1997-06-26 1999-01-19 Karolinska Innovations Ab Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
ID27676A (id) * 1997-09-11 2001-04-19 Sony Corp Peralatan elektronik
CA2303401A1 (en) 1997-10-01 1999-04-08 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
ATE346607T1 (de) 2000-09-01 2006-12-15 Philadelphia Health & Educatio Verfahren und zusammensetzungen zur inhibition der angiogenese
CN100491394C (zh) 2000-11-28 2009-05-27 大卫·M·崴斯曼 抗血管增生的多肽

Also Published As

Publication number Publication date
AU2002239366A1 (en) 2002-06-11
WO2002044328A2 (en) 2002-06-06
EP1337548A2 (de) 2003-08-27
US20090061510A1 (en) 2009-03-05
US7626008B2 (en) 2009-12-01
US7420036B2 (en) 2008-09-02
WO2002044328A3 (en) 2003-04-03
CN1498223A (zh) 2004-05-19
CN100491394C (zh) 2009-05-27
EP1337548B1 (de) 2008-07-16
EP1337548A4 (de) 2005-01-12
CA2426543A1 (en) 2002-06-06
DE60134885D1 (de) 2008-08-28
CA2426543C (en) 2007-09-18
US20040082030A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
CO5611160A2 (es) Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE60143061D1 (de) Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
ATE275583T1 (de) KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON
YU15499A (sh) Olanzapin dihidrat d
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
DE10080052T1 (de) Beratungshilfeverfahren und -einrichtungen
DK1503788T3 (da) Behandling af alpha-galactosidase A-deficiens
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
BR0107691A (pt) Sapogeninas substituìdas e seu uso
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
DE60134885D1 (de) Antiangiogene polypeptide
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DE60217539D1 (de) Leichtathletikschuh
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
DK1303294T3 (da) Fremgangsmåde til behandling af instabil angina pectoris
TR200002939T2 (tr) Paroksetin maleat
SI1276495T1 (sl) Uporaba rekombinantnega pljucnega surfaktanta za zgodnje zdravljenje akutnih pljucnih bolezni
NO20005548L (no) Mykobakterieinhibitorer
PT1173194E (pt) Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares
TR200003084T2 (tr) Paroxetine askorbat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties